# OnCo record paper-prasad-nat-rev-clin-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-prasad-nat-rev-clin-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-prasad-nat-rev-clin-oncol" ;
  schema:name "The high price of anticancer drugs: origins, implications, barriers, solutions"@en ;
  schema:description "Paper cited by one bottleneck page and 21 idea pages, indexed on Europe PMC as PubMed record 28290490 and published in Nature Reviews Clinical Oncology; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-prasad-nat-rev-clin-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/nrclinonc.2017.31>, <https://pubmed.ncbi.nlm.nih.gov/28290490/>, <https://europepmc.org/article/MED/28290490> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/nrclinonc.2017.31> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Prasad V, De Jesús K, Mailankody S" ;
  onco:related <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/ideas/idea-reg-middle-income-negotiation-bloc/>, <https://onco.cc/ideas/idea-reg-pd1-biosimilar-advance-commitment/>, <https://onco.cc/ideas/idea-reg-net-price-transparency-registry/>, <https://onco.cc/ideas/idea-reg-market-expansion-repricing/>, <https://onco.cc/ideas/idea-reg-biosimilar-first-default-switching/>, <https://onco.cc/ideas/idea-reg-patent-buyout-prize/>, <https://onco.cc/ideas/idea-reg-price-anchored-to-mcbs/>, <https://onco.cc/ideas/idea-reg-rd-cost-disclosure-condition/>, <https://onco.cc/ideas/idea-reg-tiered-pricing-for-exclusivity/>, <https://onco.cc/ideas/idea-reg-secondary-patent-thicket-limits/>, <https://onco.cc/ideas/idea-reg-indication-specific-pricing/>, <https://onco.cc/ideas/idea-reg-annuity-payment-durable-therapies/>, <https://onco.cc/ideas/idea-moon-pay-for-cure-contracts/>, <https://onco.cc/ideas/idea-moon-neoantigen-vaccines-at-scale/>, <https://onco.cc/ideas/idea-reg-provisional-price-until-os/>, <https://onco.cc/ideas/idea-reg-academic-cart-at-cost-coverage/>, <https://onco.cc/ideas/idea-reg-public-deescalation-trials-for-cost/>, <https://onco.cc/ideas/idea-reg-weight-based-io-dosing-label/>, <https://onco.cc/ideas/idea-reg-financial-toxicity-vital-sign/>, <https://onco.cc/ideas/idea-reg-social-impact-bond-switching/>, <https://onco.cc/ideas/idea-reg-io-subscription-national/> ;
  onco:journals <https://onco.cc/journals/nature-reviews-clinical-oncology/> .